- Home
- RDZN vs GNTA Comparison
RDZN vs GNTA Comparison
Compare RDZN & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- GNTA
- Stock Information
- Founded
- RDZN 2015
- GNTA 2014
- Country
- RDZN United States
- GNTA Italy
- Employees
- RDZN N/A
- GNTA N/A
- Industry
- RDZN Blank Checks
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDZN Finance
- GNTA Health Care
- Exchange
- RDZN Nasdaq
- GNTA Nasdaq
- Market Cap
- RDZN 79.4M
- GNTA 81.2M
- IPO Year
- RDZN N/A
- GNTA 2021
- Fundamental
- Price
- RDZN $0.95
- GNTA $2.85
- Analyst Decision
- RDZN Strong Buy
- GNTA Strong Buy
- Analyst Count
- RDZN 2
- GNTA 1
- Target Price
- RDZN $5.00
- GNTA $25.00
- AVG Volume (30 Days)
- RDZN 653.6K
- GNTA 11.1K
- Earning Date
- RDZN 06-26-2025
- GNTA 01-01-0001
- Dividend Yield
- RDZN N/A
- GNTA N/A
- EPS Growth
- RDZN N/A
- GNTA N/A
- EPS
- RDZN N/A
- GNTA N/A
- Revenue
- RDZN $44,296,098.00
- GNTA N/A
- Revenue This Year
- RDZN $4.52
- GNTA N/A
- Revenue Next Year
- RDZN $53.72
- GNTA N/A
- P/E Ratio
- RDZN N/A
- GNTA N/A
- Revenue Growth
- RDZN N/A
- GNTA N/A
- 52 Week Low
- RDZN $0.68
- GNTA $2.79
- 52 Week High
- RDZN $3.28
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- RDZN 46.16
- GNTA 22.05
- Support Level
- RDZN $1.00
- GNTA $2.90
- Resistance Level
- RDZN $1.22
- GNTA $3.29
- Average True Range (ATR)
- RDZN 0.12
- GNTA 0.18
- MACD
- RDZN -0.01
- GNTA -0.05
- Stochastic Oscillator
- RDZN 18.94
- GNTA 9.02
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.